par 210 par 210 (Propafenone Extended Release 325 mg)
Pill imprint par 210 par 210 has been identified as Propafenone hydrochloride extended release 325 mg.
Propafenone is used in the treatment of atrial fibrillation; atrial flutter; ventricular tachycardia; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 325 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- par 210 par 210
- Strength:
- 325 mg
- Color:
- Orange & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Par Pharmaceutical Inc
- National Drug Code (NDC):
- 49884-0210
- Inactive Ingredients:
- lactose anhydrous
magnesium stearate
povidone
FD&C Blue No. 1
gelatin
titanium dioxide
D&C Yellow No. 10
ferrosoferric oxide
butyl alcohol
propylene glycol
FD&C Blue No. 2
FD&C Red No. 40
shellac
alcohol
water
ethylcelluloses
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0917 | Amerisource Health Services |
| 42291-0546 | AvKare, Inc. |
Note: Inactive ingredients may vary.
More about propafenone
Consumer resources
- Other brands: Rythmol, Rythmol SR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
